Profile data is unavailable for this security.
About the company
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company operates through three segments: EasyDNA, AffinityDNA, and GeneType / Corporate. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and mor
- Revenue in USD (TTM)5.56m
- Net income in USD-8.32m
- Incorporated1987
- Employees60.00
- LocationGenetic Technologies Ltd60-66 Hanover St, FitzroyMELBOURNE 3065AustraliaAUS
- Phone+61 39415-1135
- Fax+61 38412-7040
- Websitehttps://www.gtglabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| avVaa World Health Care Products Inc | 39.74k | 49.55k | 2.13m | 2.00 | 73.33 | -- | 42.91 | 53.50 | 0.00003 | 0.00003 | 0.00002 | -0.0069 | 0.8149 | -- | 9.63 | -- | 101.60 | 2,695.88 | -- | -- | 95.92 | 80.55 | 124.69 | 6,316.05 | -- | -- | -- | 0.00 | 142.40 | -12.09 | 159.21 | -- | -- | -- |
| Greenbrook TMS Inc | 72.49m | -52.54m | 2.61m | 629.00 | -- | -- | -- | 0.036 | -1.24 | -1.24 | 1.71 | -2.45 | 0.9471 | -- | 6.22 | -- | -69.41 | -68.51 | -113.55 | -106.45 | 25.92 | 38.65 | -73.29 | -76.82 | -- | -2.40 | 136.38 | -- | 10.42 | 28.26 | 44.21 | -- | -54.79 | -- |
| Ethema Health Corp | 5.35m | 957.28k | 2.98m | 65.00 | 3.48 | -- | 2.37 | 0.5581 | 0.0002 | 0.0002 | 0.0014 | -0.0018 | 0.5885 | -- | 11.88 | 82,231.23 | 8.90 | -37.68 | -- | -- | -- | -- | 15.12 | -94.87 | -- | -1.08 | 4.99 | -- | 10.87 | 65.34 | 652.41 | -- | 74.97 | -- |
| CompuMed Inc | 1.78m | -151.00k | 3.69m | 8.00 | -- | 28.33 | -- | 2.07 | -0.1337 | -0.1337 | 1.58 | 0.0997 | 2.38 | 36.71 | 4.83 | -- | -19.92 | -46.77 | -48.38 | -76.78 | 50.42 | 57.04 | -8.38 | -25.84 | 0.9493 | -2.93 | 0.7744 | -- | -1.73 | -5.71 | 64.41 | -- | -18.75 | -- |
| Avalon Globocare Corp | 1.27m | -15.15m | 4.11m | 5.00 | -- | -- | -- | 3.23 | -1.37 | -1.37 | 0.1174 | 0.5452 | 0.0497 | -- | 11.48 | 254,820.00 | -59.08 | -100.94 | -79.08 | -134.51 | 18.99 | 24.44 | -1,189.45 | -1,011.06 | -- | -0.553 | 0.5784 | -- | 4.45 | -4.28 | -40.03 | -- | -51.83 | -- |
| Genetic Technologies Limited (ADR) | 5.56m | -8.32m | 4.18m | 60.00 | -- | 1.04 | -- | 0.7524 | -1.15 | -1.15 | 0.1436 | 0.819 | 0.7028 | 9.84 | 4.20 | 92,663.71 | -105.21 | -52.85 | -154.00 | -61.70 | 53.55 | 49.50 | -149.69 | -247.36 | 1.55 | -- | 0.0736 | -- | 27.83 | 114.96 | -64.79 | -- | 49.00 | -- |
| Biocorrx Inc | 52.35k | -3.99m | 5.00m | 5.00 | -- | -- | -- | 95.48 | -0.464 | -0.464 | 0.0061 | -1.21 | 0.102 | -- | 0.9969 | -- | -778.76 | -291.68 | -- | -- | 44.64 | 67.13 | -7,635.86 | -3,208.40 | -- | -3.49 | -- | -- | -58.31 | -25.04 | 13.79 | -- | -- | -- |
| Interpace Biosciences Inc | 40.66m | 1.25m | 5.03m | 108.00 | 4.10 | -- | 2.55 | 0.1238 | 0.2802 | 0.2022 | 9.27 | -3.34 | 2.90 | 14.32 | 8.37 | 376,481.50 | 8.95 | -38.19 | -- | -69.73 | 59.02 | 49.44 | 3.08 | -41.01 | 0.4355 | 3.11 | -- | -- | 26.31 | 12.93 | 118.96 | -- | 0.9184 | -- |
| Medical Care Technologies Inc. | 0.00 | -1.07m | 6.10m | 0.00 | -- | -- | -- | -- | -553,570.10 | -553,570.10 | 0.00 | -389.23 | 0.00 | -- | -- | -- | -154.94 | -- | -- | -- | -- | -- | -- | -- | -- | -1.46 | -- | -- | -- | -- | -40.06 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| G1 Execution Services LLCas of 31 Mar 2024 | 34.60k | 0.79% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 17.23k | 0.39% |
| BNP Paribas Financial Marketsas of 31 Mar 2024 | 9.10k | 0.21% |
| RhumbLine Advisers LPas of 31 Mar 2024 | 3.74k | 0.09% |
| Desjardins Securities, Inc.as of 31 Mar 2024 | 400.00 | 0.01% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 260.00 | 0.01% |
| Simplex Trading LLCas of 30 Jun 2024 | 255.00 | 0.01% |
| UBS Securities LLCas of 31 Mar 2024 | 219.00 | 0.01% |
| Wells Fargo Clearing Services LLCas of 31 Mar 2024 | 0.00 | 0.00% |
